Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis

NCT04761354 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04761354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04761354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Completed
Start date
March 26, 2016
Completion date
March 26, 2017
Enrollment
514 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism, primary aldosteronism due to aldosterone producing adenoma, primary aldosteronism due to conn adenoma